Stem cells and immunotherapy join forces against childhood brain tumors
NCT ID NCT07031765
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tests a new approach for children whose high-grade glioma has come back after standard treatments. It combines specially grown stem cells with an immunotherapy drug called nivolumab. The main goals are to see if the treatment is safe and possible to deliver, not yet to prove it works. Only 12 children will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPENDYMOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UF Health Shands Children's Hospital/Shands Hospital
Gainesville, Florida, 32608, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can trained immune cells outsmart brain tumors?
- New platform trial takes on NF2 tumors with multiple drug strategies
- Targeted pill aims to stall a common brain Tumor's growth
- Could a cancer drug shrink brain tumors and save hearing in a rare nerve disorder?
- AI reads MRI scans to reveal hidden brain tumor types in children before surgery
- New hope for brain tumor patients when standard drug fails